299 related articles for article (PubMed ID: 13631067)
1. Studies in Cushing's syndrome. III. Urinary 17-ketosteroids in patients with bilateral adrenal cortical hyperplasia.
JAILER JW; VANDE WIELE R; CHRISTY NP; LIEBERMAN S
J Clin Invest; 1959 Feb; 38(2):357-65. PubMed ID: 13631067
[No Abstract] [Full Text] [Related]
2. Cushing's syndrome. IV. Urinary 17-ketosteroids in patients with adrenal cortical tumors.
VANDE WIELE R; CHRISTY NP; LIEBERMAN S; JAILER JW
Proc Soc Exp Biol Med; 1958 Nov; 99(2):520-2. PubMed ID: 13601925
[No Abstract] [Full Text] [Related]
3. [Neutral urinary 17-ketosteroids].
COLQUE CM
Sem Med; 1953 Mar; 102(10):314-24; contd. PubMed ID: 13076497
[No Abstract] [Full Text] [Related]
4. Urinary 17-keto-steroid and 17-ketogenic steroid excretion in Cushing's syndrome.
HEIDER CH; HANDLEY CA; FORD RV
J Clin Endocrinol Metab; 1959 Nov; 19():1471-6. PubMed ID: 14400611
[No Abstract] [Full Text] [Related]
5. CONCENTRATION OF CORTICOSTERONE AND HYDROCORTISONE IN THE PLASMA OF PATIENTS WITH CUSHING'S SYNDROME CAUSED BY HYPERPLASIA OR TUMOUR OF THE ADRENAL CORTEX.
BRORSON I
Acta Chir Scand; 1964; 127():162-71. PubMed ID: 14104698
[No Abstract] [Full Text] [Related]
6. [PLASMATIC ESTROGENS IN BILATERAL HYPERPLASIA OF THE ADRENAL CORTEX. COMPARATIVE STUDY IN CONGENITAL ADRENOGENITAL SYNDROME AND CUSHING'S SYNDROME].
SCIARRA F; SORCINI G; CONCOLINO G; RASCIO L
Folia Endocrinol; 1964 Oct; 17():556-67. PubMed ID: 14265045
[No Abstract] [Full Text] [Related]
7. [Diurnal variation of 17-OHCS and 17-KS in adreno-cortical diseases, particularly in Cushing's syndrome].
HIROSE K
Nihon Hinyokika Gakkai Zasshi; 1962 Jun; 53():448-55. PubMed ID: 13907666
[No Abstract] [Full Text] [Related]
8. Cushing's syndrome due to bilateral adrenal cortical hyperplasia in a 13-year old girl: successful treatment with op'DDD'.
Sizonenko PC; Doret AM; Riondel AM; Paunier L
Helv Paediatr Acta; 1974 Aug; 29(3):195-202. PubMed ID: 4851230
[No Abstract] [Full Text] [Related]
9. The effect of cortisone on the urinary excretion of 17-ketosteroids in patients with Cushing's syndrome.
JAILER JW; LOUCHART J; GOLD JJ; KNOWLTON AI
J Clin Invest; 1953 May; 32(5):449-52. PubMed ID: 13052706
[No Abstract] [Full Text] [Related]
10. [Failure of the intravenous ACTH tests in a case of Cushing's syndrome following bilateral hyperplasia of the adrenal cortex. Postoperative substitution of a 21-desoxysteroid].
TAMM J; VOIGT KD; KRACHT J
Acta Endocrinol (Copenh); 1961 Jun; 37():253-62. PubMed ID: 13775113
[No Abstract] [Full Text] [Related]
11. [ADRENAL CORTEX FUNCTION. DETERMINATION OF THE URINARY AND PLASMATIC 17,21-DIHYDROXY-20-KETOSTEROIDS IN THE DIAGNOSIS OF CUSHING'S SYNDROME].
WAJCHENBERG BL
Arq Bras Endocrinol Metabol; 1963 Dec; 12():153-76. PubMed ID: 14164197
[No Abstract] [Full Text] [Related]
12. [Morphology of the adrenal cortex in Cushing's syndrome].
Flattet A; Hedinger C
Schweiz Med Wochenschr; 1980 Sep; 110(36):1300-6. PubMed ID: 7444415
[TBL] [Abstract][Full Text] [Related]
13. Qualitative differences in urinary 17-ketosteroid excretion in patients with Cushing's syndrome.
KOVACIC N; MATOVINOVIC J; PROSENJAK M
Acta Endocrinol (Copenh); 1957 Apr; 24(4):393-401. PubMed ID: 13434688
[No Abstract] [Full Text] [Related]
14. Urinary formaldehydrogenic corticoid as determined after enzymatic hydrolysis in normal subjects and in patients with adrenal and hypertensive disease.
DUSTAN HP; MASON HL; CORCORAN AC
J Clin Invest; 1953 Jan; 32(1):60-7. PubMed ID: 13011209
[No Abstract] [Full Text] [Related]
15. [Determination of urinary steroids in adrenocortical hyperfunction].
JAKOBSON T
Duodecim; 1959; 75():808-17. PubMed ID: 13853081
[No Abstract] [Full Text] [Related]
16. Determination of the 17-ketosteroid and corticoid output in cases of Cushing's syndrome caused by hyperplasia and adenoma.
DAHL-IVERSEN E
Acta Chir Scand Suppl; 1960; Suppl 253():28-32. PubMed ID: 13813714
[No Abstract] [Full Text] [Related]
17. The clinical significance of urinary 17-ketosteroid assays.
BISKIND GR
Calif Med; 1950 Mar; 72(3):148-52. PubMed ID: 15405026
[TBL] [Abstract][Full Text] [Related]
18. Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing's syndrome.
DOE RP; VENNES JA; FLINK EB
J Clin Endocrinol Metab; 1960 Feb; 20():253-65. PubMed ID: 13817162
[No Abstract] [Full Text] [Related]
19. CORTICOSTERONE IN THE TREATMENT OF CUSHING'S SYNDROME CAUSED BY ADRENAL CORTICAL HYPERPLASIA.
BRORSON I
Acta Chir Scand; 1964 Apr; 127():406-14. PubMed ID: 14149643
[No Abstract] [Full Text] [Related]
20. Fluctuating steroid excretion in Cushing's syndrome.
BASSOE HH; EMBERLAND R; STOA KF
Acta Endocrinol (Copenh); 1958 Jun; 28(2):163-8. PubMed ID: 13532390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
